Skip to content

Atazanavir sulfate

Reyataz (atazanavir sulfate) is a small molecule pharmaceutical. Atazanavir sulfate was first approved as Reyataz on 2004-03-01. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.
Trade Name Reyataz
Common Name Atazanavir sulfate
Indication acquired immunodeficiency syndrome, hiv infections
Drug Class Antivirals: HIV protease inhibitors (saquinavir type)
Atazanavir sulfate
Get full access now